{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:23:15Z","timestamp":1784600595583,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016951","name":"UCLA AIDS Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016951","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.xcrm.2020.100162","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T11:53:28Z","timestamp":1608638008000},"page":"100162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Tracking HIV Rebound following Latency Reversal Using Barcoded HIV"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4857-8712","authenticated-orcid":false,"given":"Matthew D.","family":"Marsden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0328-315X","authenticated-orcid":false,"given":"Melanie","family":"Dimapasoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1892-4917","authenticated-orcid":false,"given":"Mohamed S.A.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7040-5773","authenticated-orcid":false,"given":"Jocelyn T.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Schrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Wender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome A.","family":"Zack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2020.100162_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/77481","article-title":"Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy","volume":"6","author":"Chun","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2020.100162_bib3","doi-asserted-by":"crossref","first-page":"15109","DOI":"10.1073\/pnas.96.26.15109","article-title":"HIV-1 and T\u00a0cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression","volume":"96","author":"Davey","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2020.100162_bib4","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2020.100162_bib5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2020.100162_bib6","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1016\/j.bmcl.2013.05.032","article-title":"HIV\/AIDS eradication","volume":"23","author":"Marsden","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.xcrm.2020.100162_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-virology-101416-041703","article-title":"Humanized Mouse Models for Human Immunodeficiency Virus Infection","volume":"4","author":"Marsden","year":"2017","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.xcrm.2020.100162_bib8","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nm1431","article-title":"Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1","volume":"12","author":"Melkus","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2020.100162_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1128\/JVI.06366-11","article-title":"HIV latency in the humanized BLT mouse","volume":"86","author":"Marsden","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100162_bib10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/JVI.06120-11","article-title":"Generation of HIV latency in humanized BLT mice","volume":"86","author":"Denton","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100162_bib11","doi-asserted-by":"crossref","first-page":"e02086-e18","DOI":"10.1128\/JVI.02086-18","article-title":"Humanized mouse model of HIV-1 latency with enrichment of latent virus in PD-1+ and TIGIT+ CD4 T\u00a0cells","volume":"93","author":"Llewellyn","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100162_bib12","doi-asserted-by":"crossref","first-page":"e1006575","DOI":"10.1371\/journal.ppat.1006575","article-title":"In\u00a0vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell \u201ckick\u201d and \u201ckill\u201d in strategy for virus eradication","volume":"13","author":"Marsden","year":"2017","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.xcrm.2020.100162_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12977-016-0268-7","article-title":"In\u00a0vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection","volume":"13","author":"Tsai","year":"2016","journal-title":"Retrovirology"},{"key":"10.1016\/j.xcrm.2020.100162_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12977-020-00516-2","article-title":"Benefits and limitations of humanized mice in HIV persistence studies","volume":"17","author":"Marsden","year":"2020","journal-title":"Retrovirology"},{"key":"10.1016\/j.xcrm.2020.100162_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/9498","article-title":"Effect of interleukin-2 on the pool of latently infected, resting CD4+ T\u00a0cells in HIV-1-infected patients receiving highly active anti-retroviral therapy","volume":"5","author":"Chun","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2020.100162_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"Archin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2020.100162_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.celrep.2012.09.008","article-title":"Reactivation of latent HIV-1 by inhibition of BRD4","volume":"2","author":"Zhu","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2020.100162_bib18","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1182\/blood.V98.10.3006","article-title":"Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART","volume":"98","author":"Kulkosky","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2020.100162_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virol.2018.05.006","article-title":"Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents","volume":"520","author":"Marsden","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.xcrm.2020.100162_bib20","doi-asserted-by":"crossref","first-page":"e1005066","DOI":"10.1371\/journal.ppat.1005066","article-title":"Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation","volume":"11","author":"Jiang","year":"2015","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.xcrm.2020.100162_bib21","doi-asserted-by":"crossref","first-page":"e01361-e18","DOI":"10.1128\/AAC.01361-18","article-title":"Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency Reversal","volume":"62","author":"Spivak","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.xcrm.2020.100162_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1074-7613(03)00236-X","article-title":"Molecular characterization, reactivation, and depletion of latent HIV","volume":"19","author":"Brooks","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2020.100162_bib23","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1172\/JCI80142","article-title":"Ex\u00a0vivo analysis identifies effective HIV-1 latency-reversing drug combinations","volume":"125","author":"Laird","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2020.100162_bib24","doi-asserted-by":"crossref","first-page":"11698","DOI":"10.1073\/pnas.1302634110","article-title":"Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in\u00a0vitro and ex\u00a0vivo","volume":"110","author":"Beans","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2020.100162_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nchem.1395","article-title":"Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in\u00a0vitro","volume":"4","author":"DeChristopher","year":"2012","journal-title":"Nat. Chem."},{"key":"10.1016\/j.xcrm.2020.100162_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nsmb.3328","article-title":"Position effects influence HIV latency reversal","volume":"24","author":"Chen","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.xcrm.2020.100162_bib27","doi-asserted-by":"crossref","first-page":"e1006359","DOI":"10.1371\/journal.ppat.1006359","article-title":"Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy","volume":"13","author":"Fennessey","year":"2017","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.xcrm.2020.100162_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jviromet.2005.10.016","article-title":"A novel small reporter gene and HIV-1 fitness assay","volume":"133","author":"Ali","year":"2006","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.xcrm.2020.100162_bib29","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa1302976","article-title":"Absence of detectable HIV-1 viremia after treatment cessation in an infant","volume":"369","author":"Persaud","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2020.100162_bib30","doi-asserted-by":"crossref","first-page":"8540","DOI":"10.1128\/JVI.00522-15","article-title":"Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next-Generation Sequencing of HIV-1 Genomic RNA Populations","volume":"89","author":"Zhou","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100162_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2217\/fvl-2018-0205","article-title":"HIV cure strategies: a complex approach for a complicated viral reservoir?","volume":"14","author":"Marsden","year":"2019","journal-title":"Future Virol."},{"key":"10.1016\/j.xcrm.2020.100162_bib32","doi-asserted-by":"crossref","first-page":"100037","DOI":"10.1016\/j.xcrm.2020.100037","article-title":"Pharmacological Activation of Non-canonical NF-kappa B Signaling Activates Latent HIV-1 Reservoirs In\u00a0Vivo","volume":"1","author":"Pache","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2020.100162_bib33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1006\/meth.1997.0488","article-title":"Preparation and maintenance of SCID-hu mice for HIV research","volume":"12","author":"Bristol","year":"1997","journal-title":"Methods"},{"key":"10.1016\/j.xcrm.2020.100162_bib34","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.2971269","article-title":"The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function","volume":"241","author":"McCune","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2020.100162_bib35","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1038\/mtna.2015.3","article-title":"RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice","volume":"4","author":"Shimizu","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.xcrm.2020.100162_bib37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jmb.2015.12.012","article-title":"A Comprehensive Analysis of Primer IDs to Study Heterogeneous HIV-1 Populations","volume":"428","author":"Seifert","year":"2016","journal-title":"J Mol Biol"},{"key":"10.1016\/j.xcrm.2020.100162_bib36","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/bioinformatics\/btl158","article-title":"Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences","volume":"22","author":"Li","year":"2006","journal-title":"Bioinformatics"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379120302093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379120302093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:46:37Z","timestamp":1762987597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379120302093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2666379120302093"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2020.100162","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tracking HIV Rebound following Latency Reversal Using Barcoded HIV","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2020.100162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100162"}}